Cargando…
Protective effects of farnesyltransferase inhibitor on sepsis-induced morphological aberrations of mitochondria in muscle and increased circulating mitochondrial DNA levels in mice
Sepsis remains a leading cause of mortality in critically ill patients and is characterized by multi-organ dysfunction. Mitochondrial damage has been proposed to be involved in the pathophysiology of sepsis. In addition to metabolic impairments resulting from mitochondrial dysfunction, mitochondrial...
Autores principales: | Tsuji, Daisuke, Nakazawa, Harumasa, Yorozu, Tomoko, Kaneki, Masao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757346/ https://www.ncbi.nlm.nih.gov/pubmed/33845310 http://dx.doi.org/10.1016/j.bbrc.2021.03.141 |
Ejemplares similares
-
Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir/ritonavir)-induced lipodystrophy and metabolic syndrome in mice
por: Tanaka, Tomokazu, et al.
Publicado: (2018) -
Coenzyme Q10 protects against burn‐induced mitochondrial dysfunction and impaired insulin signaling in mouse skeletal muscle
por: Nakazawa, Harumasa, et al.
Publicado: (2019) -
Farnesysltransferase Inhibitor Prevents Burn Injury-Induced Metabolome Changes in Muscle
por: Nakazawa, Harumasa, et al.
Publicado: (2022) -
Effect of farnesyltransferase inhibitor on the function of mitochondria of Plasmodium falciparum
por: Ha, Young Ran, et al.
Publicado: (2012) -
Burn-induced muscle metabolic derangements and mitochondrial dysfunction are associated with activation of HIF-1α and mTORC1: Role of protein farnesylation
por: Nakazawa, Harumasa, et al.
Publicado: (2017)